Targeting Lysosomal-Associated Membrane Protein 2 (LAMP2) as a Potential Target to Inhibit Autophagosome-Lysosome Fusion and Improve the Response to Anti-Cancer Therapies. This evidence concerns the gene LAMP2 and cancer.